Evan  Roberts net worth and biography

Evan Roberts Biography and Net Worth

COO of Phreesia
Since co-founding Phreesia in 2005, Evan Roberts has led the company’s efforts to bring the highest value to its clients. As Chief Operating Officer, he leads Phreesia’s Customer Solutions and Product Management teams. He previously served as Chief Technology Officer and also Vice President, Customer Solutions, where he was responsible for bringing Phreesia’s patient intake management solutions to healthcare organizations across the country.

Prior to co-founding Phreesia, Evan was a senior sales engineer at Spotfire, where he helped to penetrate new markets, resulting in significant net new revenue. There, he developed innovative applications and trained and managed his team to support and nurture these new markets. He holds a BS in computer engineering from Tufts University.

What is Evan Roberts' net worth?

The estimated net worth of Evan Roberts is at least $15.79 million as of October 15th, 2024. Mr. Roberts owns 753,876 shares of Phreesia stock worth more than $15,793,702 as of December 3rd. This net worth approximation does not reflect any other investments that Mr. Roberts may own. Additionally, Mr. Roberts receives a salary of $400,000.00 as COO at Phreesia. Learn More about Evan Roberts' net worth.

How old is Evan Roberts?

Mr. Roberts is currently 45 years old. There are 5 older executives and no younger executives at Phreesia. The oldest executive at Phreesia is Ms. Janet M. Gunzburg, VP, Principal Accounting Officer & Controller, who is 58 years old. Learn More on Evan Roberts' age.

What is Evan Roberts' salary?

As the COO of Phreesia, Inc., Mr. Roberts earns $400,000.00 per year. There are 3 executives that earn more than Mr. Roberts. The highest earning executive at Phreesia is Mr. David Linetsky, Senior Vice President of Life Sciences, who commands a salary of $551,640.00 per year. Learn More on Evan Roberts' salary.

How do I contact Evan Roberts?

The corporate mailing address for Mr. Roberts and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Evan Roberts' contact information.

Has Evan Roberts been buying or selling shares of Phreesia?

Within the last three months, Evan Roberts has sold $38,758.29 in shares of Phreesia stock. Most recently, Evan Roberts sold 1,843 shares of the business's stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $21.03, for a transaction totalling $38,758.29. Following the completion of the sale, the chief operating officer now directly owns 753,876 shares of the company's stock, valued at $15,854,012.28. Learn More on Evan Roberts' trading history.

Who are Phreesia's active insiders?

Phreesia's insider roster includes Edward Cahill (Director), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.

Are insiders buying or selling shares of Phreesia?

In the last twelve months, insiders at the sold shares 56 times. They sold a total of 151,985 shares worth more than $3,552,098.43. The most recent insider tranaction occured on October, 18th when SVP David Linetsky sold 1,100 shares worth more than $22,539.00. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.

Information on this page was last updated on 10/18/2024.

Evan Roberts Insider Trading History at Phreesia

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2024Sell1,843$21.03$38,758.29753,876View SEC Filing Icon  
9/10/2024Sell3,148$23.25$73,191.00755,719View SEC Filing Icon  
7/16/2024Sell1,669$23.74$39,622.06753,234View SEC Filing Icon  
4/15/2024Sell2,029$22.86$46,382.94754,903View SEC Filing Icon  
4/8/2024Sell7,178$22.62$162,366.36733,602View SEC Filing Icon  
3/21/2024Sell25,962$23.52$610,626.24728,570View SEC Filing Icon  
1/16/2024Sell2,247$24.55$55,163.85795,613View SEC Filing Icon  
10/16/2023Sell1,971$16.61$32,738.31745,860View SEC Filing Icon  
9/13/2023Sell3,907$20.34$79,468.38747,831View SEC Filing Icon  
4/17/2023Sell2,600$32.01$83,226.00724,412View SEC Filing Icon  
4/12/2023Sell200$32.01$6,402.00728,793View SEC Filing Icon  
6/28/2021Sell32,075$60.38$1,936,688.50View SEC Filing Icon  
6/24/2021Sell21,091$60.05$1,266,514.55View SEC Filing Icon  
6/15/2021Sell20,000$56.04$1,120,800.00View SEC Filing Icon  
1/19/2021Sell5,500$63.87$351,285.00View SEC Filing Icon  
1/4/2021Sell80,245$52.48$4,211,257.60View SEC Filing Icon  
10/1/2020Sell14,774$30.93$456,959.82View SEC Filing Icon  
7/1/2020Sell12,500$28.45$355,625.00View SEC Filing Icon  
1/27/2020Sell69,448$29.17$2,025,798.16632,343View SEC Filing Icon  
See Full Table

Evan Roberts Buying and Selling Activity at Phreesia

This chart shows Evan Roberts's buying and selling at Phreesia by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Phreesia Company Overview

Phreesia logo
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Read More

Today's Range

Now: $20.95
Low: $20.82
High: $21.45

50 Day Range

MA: $20.43
Low: $18.04
High: $23.49

2 Week Range

Now: $20.95
Low: $14.55
High: $29.16

Volume

74,502 shs

Average Volume

444,412 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98